D6571
3′,4′-二甲氧基黄酮
别名:
2-（3,4-二甲氧基苯基）苯并吡喃-4-酮, 3′,4′-DMF
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C17H14O4
化学文摘社编号:
分子量:
282.29
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
InChI
1S/C17H14O4/c1-19-15-8-7-11(9-17(15)20-2)16-10-13(18)12-5-3-4-6-14(12)21-16/h3-10H,1-2H3
SMILES string
COc1ccc(cc1OC)C2=CC(=O)c3ccccc3O2
InChI key
ZGHORMOOTZTQFL-UHFFFAOYSA-N
assay
≥98% (HPLC)
form
powder
color
white to off-white
solubility
DMSO: ≥20 mg/mL
storage temp.
room temp
Quality Level
Application
3′,4′-二甲氧基黄酮已被用于脲酶抑制试验。
Biochem/physiol Actions
3′,4′-二甲氧基黄酮是AhR的竞争性拮抗剂，其可抑制AhR介导的CYP1A1诱导，并且还在乳腺肿瘤细胞系中显示出抗雌激素活性。该化合物可阻断细胞溶质AhR复合物的转化，并形成核AhR复合物。
3′,4′-二甲氧基黄酮是一种黄酮化合物，其具有防止聚（ADP-核糖）（PAR）聚合物的产生和积累的能力。它可在皮质神经元中防御 N-甲基-D-天冬氨酸（NMDA）的毒性。3′,4′-二甲氧基黄酮是植物来源的多酚类黄酮类的成员。已知它具有抗氧化、抗癌、抗炎、抗动脉粥样硬化、降血脂和神经保护或神经营养作用。
3′,4′-二甲氧基黄酮是芳香烃受体（AhR）的竞争性拮抗剂，其可抑制AhR介导的CYP1A1诱导，并且还在乳腺肿瘤细胞系中显示出抗雌激素活性。
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Oral
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Flavonoids as natural inhibitors of jack bean urease Enzyme
AJ Awllia, et al.
Letters in Drug Design & Discovery, 13(3), 243-249 (2016)
Identification through high-throughput screening of 4'-methoxyflavone and 3', 4'-dimethoxyflavone as novel neuroprotective inhibitors of parthanatos
Fatokun AA, et al.
British Journal of Pharmacology, 169(6), 1263-1278 (2013)
Dan J M Nguyen et al.
Molecular cancer research : MCR, 18(1), 105-117 (2019-10-20)
Cisplatin resistance is a major barrier in the effective treatment of lung cancer. Cisplatin-resistant (CR) lung cancer cells do not primarily use glucose but rather consume amino acids such as glutamine and tryptophan (Trp) for survival. CR cells activate the
Nada H Eisa et al.
International journal of molecular sciences, 21(21) (2020-10-30)
There is increasing evidence of the involvement of the tryptophan metabolite kynurenine (KYN) in disrupting osteogenesis and contributing to aging-related bone loss. Here, we show that KYN has an effect on bone resorption by increasing osteoclastogenesis. We have previously reported
Ke Wang et al.
International journal of molecular sciences, 16(7), 16454-16468 (2015-07-25)
Exposure to aristolochic acid I (AAI) can lead to aristolochic acid nephropathy (AAN), Balkan endemic nephropathy (BEN) and urothelial cancer. The induction of hepatic CYP1A, especially CYP1A2, was considered to detoxify AAI so as to reduce its nephrotoxicity. We previously
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持